Citations

Clear

6273 citation(s) found for "To, Andrew".

Preoperative platelet transfusions and perioperative red blood cell requirements in patients with thrombocytopenia undergoing noncardiac surgery
Warner, Matthew A. , Jia, Qing , Clifford, Leanne, Wilson, Gregory , Brown, Michael , Hanson, Andrew C. , Schroeder, Darrell R. , Kor, Daryl J. , Warner, Matthew A , Schroeder, Darrell

Mayo Clinic

Transfusion | November 11, 2015 | Volume: 56 | Issue: 3 | Pages: 682-690

10.1111/trf.13414 | PMID 26559936 Get It

BACKGROUNDPerioperative hemorrhage impacts patient outcomes and health care resource utilization, yet the risks of transfusion therapies are significant. In patients with preoperative thrombocytopenia, the effects of prophylactic preoperative platelet (PLT) transfusion on perioperative bleeding complications remain uncertain.STUDY DESIGN AND METHODSThis is a retrospective cohort study of noncardiac surgical patients between January 1, 2008, and December 31, 2011. Propensity‐adjusted analyses were used to evaluate associations between preoperative thrombocytopenia, preoperative PLT transfusion, and the outcomes of interest, with a primary outcome of perioperative red blood cell (RBC) transfusion.RESULTSA total of 13,978 study participants were included; 860 (6.2%) had a PLT count of not more than 100 × 109/L with 71 (8.3%) receiving PLTs preoperatively. Administration of PLTs was associated with higher rates of perioperative RBC transfusion (66.2% vs. 49.1%, p = 0.0065); however, in propensity‐adjusted analysis there was no significant difference between groups (odds ratio [OR] [95% confidence interval {95% CI}], 1.68 [0.95‐2.99]; p = 0.0764]. Patients receiving PLTs had higher rates of intensive care unit (ICU) admission (OR [95% CI], 1.95 [1.10‐3.46]; p = 0.0224) and longer hospital lengths of stay (estimate [95% bootstrap CI], 7.2 [0.8‐13.9] days; p = 0.0006) in propensity‐adjusted analyses.CONCLUSIONPreoperative PLT transfusion did not attenuate RBC requirements in patients with thrombocytopenia undergoing noncardiac surgery. Moreover, preoperative PLT transfusion was associated with increased ICU admission rates and hospital duration. These findings suggest that more conservative management of preoperative thrombocytopenia may be warranted.
β-Glucan–Activated Human B Lymphocytes Participate in Innate Immune Responses by Releasing Proinflammatory Cytokines and Stimulating Neutrophil Chemotaxis
Ali, Mohamed F. , Driscoll, Christopher B. , Walters, P. , Carmona, Eva M. , Walters, Paula R, Limper, Andrew H. , Carmona, Eva M , Driscoll, Christopher

Mayo Clinic

The Journal of Immunology | October 31, 2015 | Volume: 195 | Issue: 11 | Pages: 5318-5326

10.4049/jimmunol.1500559 | PMID 26519534 Get It

Abstract B lymphocytes play an essential regulatory role in the adaptive immune response through Ab production during infection. A less known function of B lymphocytes is their ability to respond directly to infectious Ags through stimulation of pattern recognition receptors expressed on their surfaces. β-Glucans are carbohydrates present in the cell wall of many pathogenic fungi that can be detected in the peripheral blood of patients during infection. They have been shown to participate in the innate inflammatory response, as they can directly activate peripheral macrophages and dendritic cells. However, their effect as direct stimulators of B lymphocytes has not been yet fully elucidated. The aim of this study was to examine the molecular mechanisms and cytokine profiles generated following β-glucan stimulation of B lymphocytes, compared with the well-established TLR-9 agonist CpG oligodeoxynucleotide (CpG), and study the participation of β-glucan–stimulated B cells in the innate immune response. In this article, we demonstrate that β-glucan–activated B lymphocytes upregulate proinflammatory cytokines (TNF-α, IL-6, and IL-8). Of interest, β-glucan, unlike CpG, had no effect on B lymphocyte proliferation or IgM production. When compared with CpG (TLR9 agonist), β-glucan–activated cells secreted significantly higher levels of IL-8. Furthermore, IL-8 secretion was partially mediated by Dectin-1 and required SYK, MAPKs, and the transcription factors NF-κB and AP-1. Moreover, we observed that conditioned media from β-glucan–stimulated B lymphocytes elicited neutrophil chemotaxis. These studies suggest that β-glucan–activated B lymphocytes have an important and novel role in fungal innate immune responses.
Associations between Cardioembolic Stroke and Obstructive Sleep Apnea
Lipford, Melissa C. , Flemming, Kelly D. , Calvin, Andrew D. , Mandrekar, Jay , Brown, Robert D. , Caples, Sean M., Somers, Virend K. , Calvin, Andrew D , Flemming, Kelly D

Mayo Clinic

Sleep | October 30, 2015 | Volume: 38 | Issue: 11 | Pages: 1699-1705

10.5665/sleep.5146 | PMID 26237769 Get It

Penetrating head injuries in children due to BB and pellet guns: a poorly recognized public health risk
Kumar, Ravi , Kumar, Ramesh , Mallory, Grant W., Jacob, Jeffrey T. , Wetjen, Nicholas M. , Foy, Andrew , O’Neill, Brent R., Daniels, David J. , Clarke, Michelle J.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | October 24, 2015 | Volume: 17 | Issue: 2 | Pages: 215-221

10.3171/2015.6.peds15148 | PMID 26496633 Get It

OBJECT Nonpowder guns, defined as spring- or gas-powered BB or pellet guns, can be dangerous weapons that are often marketed to children. In recent decades, advances in compressed-gas technology have led to a significant increase in the power and muzzle velocity of these weapons. The risk of intracranial injury in children due to nonpowder weapons is poorly documented. METHODS A retrospective review was conducted at 3 institutions studying children 16 years or younger who had intracranial injuries secondary to nonpowder guns. RESULTS The authors reviewed 14 cases of intracranial injury in children from 3 institutions. Eleven (79%) of the 14 children were injured by BB guns, while 3 (21%) were injured by pellet guns. In 10 (71%) children, the injury was accidental. There was 1 recognized assault, but there were no suicide attempts; in the remaining 3 patients, the intention was indeterminate. There were no mortalities among the patients in this series. Ten (71%) of the children required operative intervention, and 6 (43%) were left with permanent neurological injuries, including epilepsy, cognitive deficits, hydrocephalus, diplopia, visual field cut, and blindness. CONCLUSIONS Nonpowder guns are weapons with the ability to penetrate a child’s skull and brain. Awareness should be raised among parents, children, and policy makers as to the risk posed by these weapons.
Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes
Giesbrandt, Kirk J., Bulatao, Ilynn , Nguyen, Justin H. , Paz‐Fumagalli, Ricardo , Bulatao, Ilynn G, Taner, C. Burcin , Keaveny, Andrew P.

Mayo Clinic

American Journal of Roentgenology | October 24, 2015 | Volume: 205 | Issue: 5 | Pages: 976-984

10.2214/ajr.14.13383 | PMID 26496544 Get It

Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma
Jaïs, Jean‐Philippe , Ghesquières, Hervé , Thompson, Carrie A. , Thiéblemont, Catherine , Micallef, Ivana N. , Porrata, Luis F. , Nowakowski, G. S., Casasnovas, Olivier , Bologna, Serge, Morrison, Vicki A., Macon, William R. , Copie‐Bergman, Christiane , Feldman, Andrew L. , Syrbu, Sergei , Kurtin, Paul J. , Gascoyne, Randy D. , Li, Hailun , Allmer, Cristine, Ansell, Stephen M. , Link, Brian K. , Salles, Gilles , Tilly, Hervé , Nowakowski, Gregorz S, Maurer, Matthew J. , Witzig, Thomas E. , Hong, Fangxin , Haïoun, Corinne , Ribrag, Vincent , Morschhauser, Franck , Peterson, Bruce A. , Kahl, Brad S. , Slager, Susan L. , Habermann, Thomas M. , Cerhan, James R. , Feldman, Andrew L , Link, Brian K , Salles, Gilles A , Syrbu, Sergei , Casasnovas, René-Olivier

Mayo Clinic

American Journal of Hematology | October 22, 2015 | Volume: 91 | Issue: 2 | Pages: 179-184

10.1002/ajh.24223 | PMID 26492520 Get It

We recently defined event‐free survival at 24 months (EFS24) as a clinically relevant outcome for patients with DLBCL. Patients who fail EFS24 have very poor overall survival, while those who achieve EFS24 have a subsequent overall survival equivalent to that of the age‐ and sex‐matched general population. Here, we develop and validate a clinical risk calculator (IPI24) for EFS24. Model building was performed on a discovery dataset of 1,348 patients with DLBCL and treated with anthracycline‐based immunochemotherapy. A multivariable model containing age, Ann Arbor stage, normalized serum LDH, ALC, ECOG performance status, bulky disease, and sex was identified. The model was then applied to an independent validation dataset of 1,177 DLBCL patients. The IPI24 score estimates the probability of failing to achieve the EFS24 endpoint for an individual patient. The IPI24 model showed superior discriminatory ability (c‐statistic = 0.671) in the validation dataset compared to the IPI (c‐statistic = 0.649) or the NCCN‐IPI (c‐statistic = 0.657). After recalibration of the model on the combined dataset, the median predicted probability of failing to achieve EFS24 was 36% (range, 12–88%), and the IPI24 showed an EFS24 gradient in all IPI groups. The IPI24 also identified a significant percentage of patients with high risk disease, with over 20% of patients having a 50% or higher risk of failing to achieve EFS24. The IPI24 provides an individual patient level probability of achieving the clinically relevant EFS24 endpoint. It can be used via electronic apps. Am. J. Hematol. 91:179–184, 2016. © 2015 Wiley Periodicals, Inc.
Cystic Fibrosis Transmembrane Conductance Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle. Implications for Airway Contractility
Cook, Daniel P. , Rector, Michael V., Bouzek, Drake C. , Michalski, Andrew S. , Gansemer, Nicholas D. , Reznikov, Leah R. , Li, Xiaopeng , Stroik, Mallory R. , Ostedgaard, Lynda S. , Alaiwa, Mahmoud H. Abou , Prakash, Y. S. , Krishnan, Ramaswamy , Meyerholz, David K. , Seow, Chun Y. , Stoltz, David A. , Thompson, Michael A. , Prakash, Y S

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | October 21, 2015 | Volume: 193 | Issue: 4 | Pages: 417-426

10.1164/rccm.201508-1562oc | PMID 26488271 Get It

Abstract Rationale An asthma-like airway phenotype has been described in people with cystic fibrosis (CF). Whether these findings are directly caused by loss of CF transmembrane conductance regulator (CFTR) function or secondary to chronic airway infection and/or inflammation has been difficult to determine. Objectives Airway contractility is primarily determined by airway smooth muscle. We tested the hypothesis that CFTR is expressed in airway smooth muscle and directly affects airway smooth muscle contractility. Methods Newborn pigs, both wild type and with CF (before the onset of airway infection and inflammation), were used in this study. High-resolution immunofluorescence was used to identify the subcellular localization of CFTR in airway smooth muscle. Airway smooth muscle function was determined with tissue myography, intracellular calcium measurements, and regulatory myosin light chain phosphorylation status. Precision-cut lung slices were used to investigate the therapeutic potential of CFTR modulation on airway reactivity. Measurements and Main Results We found that CFTR localizes to the sarcoplasmic reticulum compartment of airway smooth muscle and regulates airway smooth muscle tone. Loss of CFTR function led to delayed calcium reuptake following cholinergic stimulation and increased myosin light chain phosphorylation. CFTR potentiation with ivacaftor decreased airway reactivity in precision-cut lung slices following cholinergic stimulation. Conclusions Loss of CFTR alters porcine airway smooth muscle function and may contribute to the airflow obstruction phenotype observed in human CF. Airway smooth muscle CFTR may represent a therapeutic target in CF and other diseases of airway narrowing.
AKI after Transcatheter or Surgical Aortic Valve Replacement
Cheungpasitporn, Wisit , Srivali, Narat , Harrison, Andrew M. , Gunderson, Tina M. , Kittanamongkolchai, Wonngarm , Greason, Kevin L. , Thongprayoon, Charat , Kashani, Kianoush , Harrison, Andrew Marc , Cheungpasitporn, Wisit , Srivali, Narat

Mayo Clinic

Journal of the American Society of Nephrology | October 20, 2015 | Volume: 27 | Issue: 6 | Pages: 1854-1860

10.1681/asn.2015050577 | PMID 26487562 Get It

Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic valve replacement (SAVR) for patients with symptomatic severe aortic stenosis who are at high risk of perioperative mortality. Previous studies showed increased risk of postoperative AKI with TAVR, but it is unclear whether differences in patient risk profiles confounded the results. To conduct a propensity-matched study, we identified all adult patients undergoing isolated aortic valve replacement for aortic stenosis at Mayo Clinic Hospital in Rochester, Minnesota from January 1, 2008 to June 30, 2014. Using propensity score matching on the basis of clinical characteristics and preoperative variables, we compared the postoperative incidence of AKI, defined by Kidney Disease Improving Global Outcomes guidelines, and major adverse kidney events in patients treated with TAVR with that in patients treated with SAVR. Major adverse kidney events were the composite of in-hospital mortality, use of RRT, and persistent elevated serum creatinine ≥200% from baseline at hospital discharge. Of 1563 eligible patients, 195 matched pairs (390 patients) were created. In the matched cohort, baseline characteristics, including Society of Thoracic Surgeons risk score and eGFR, were comparable between the two groups. Furthermore, no significant differences existed between the TAVR and SAVR groups in postoperative AKI (24.1% versus 29.7%; P =0.21), major adverse kidney events (2.1% versus 1.5%; P =0.70), or mortality >6 months after surgery (6.0% versus 8.3%; P =0.51). Thus, TAVR did not affect postoperative AKI risk. Because it is less invasive than SAVR, TAVR may be preferred in high-risk individuals.
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy
Harrison, Andrew M. , Héritier, F , Childs, Bennett G. , Bostwick, John , Dziadzko, Mikhail , Bostwick, J Michael, Dziadzko, Mikhail A, Harrison, Andrew Marc

Mayo Clinic

BioMed Research International | October 20, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-8

10.1155/2015/506327 | PMID 26576425 Get It

Pain in cancer therapy is a common condition and there is a need for new options in therapeutic management. While phytochemicals have been proposed as one pain management solution, knowledge of their utility is limited. The objective of this study was to perform a systematic review of the biomedical literature for the use of phytochemicals for management of cancer therapy pain in human subjects. Of an initial database search of 1,603 abstracts, 32 full-text articles were eligible for further assessment. Only 7 of these articles met all inclusion criteria for this systematic review. The average relative risk of phytochemical versus control was 1.03 [95% CI 0.59 to 2.06]. In other words (although not statistically significant), patients treated with phytochemicals were slightly more likely than patients treated with control to obtain successful management of pain in cancer therapy. We identified a lack of quality research literature on this subject and thus were unable to demonstrate a clear therapeutic benefit for either general or specific use of phytochemicals in the management of cancer pain. This lack of data is especially apparent for psychotropic phytochemicals, such as theCannabisplant (marijuana). Additional implications of our findings are also explored.